For individuals already stable on daily buprenorphine (Suboxone), Sublocade offers a significant upgrade: one injection per month replaces daily medication, removing the burden of daily dosing, reducing diversion potential, and providing smoother, more consistent relief from cravings. The extended-release formulation maintains steady medication levels without the peaks and troughs that can occur with daily dosing.
Sublocade is part of our comprehensive Medication-Assisted Treatment (MAT) program at Addiction Recovery Center. Our medical team evaluates whether Sublocade is appropriate for your situation – typically for those who have achieved stability on daily buprenorphine and are ready to transition to monthly injections. Same-day assessments are available when you are ready to explore this option.
Contact Addiction Recovery Center at (866) 502-4344 or visit our Contact Us page for a free, confidential assessment to begin your journey toward recovery and renewed hope.
Factor | Sublocade | Suboxone | Vivitrol |
Medication Type | Partial opioid agonist | Partial opioid agonist | Opioid antagonist (blocker) |
Active Ingredient | Buprenorphine | Buprenorphine/naloxone | Naltrexone |
Administration | Monthly subcutaneous injection | Daily sublingual film/tablet | Monthly intramuscular injection |
Requires Prior Buprenorphine | Yes (must be stable on daily buprenorphine first) | No (can initiate directly) | No |
Prevents Withdrawal | Yes | Yes | No (requires completed detox) |
Blocks Other Opioids | Partially | Partially | Completely |
| Factor | Sublocade | Suboxone | Vivitrol |
| Medication Type | Partial opioid agonist | Partial opioid agonist | Opioid antagonist (blocker) |
| Active Ingredient | Buprenorphine | Buprenorphine/naloxone | Naltrexone |
| Administration | Monthly subcutaneous injection | Daily sublingual film/tablet | Monthly intramuscular injection |
| Requires Prior Buprenorphine | Yes (must be stable on daily buprenorphine first) | No (can initiate directly) | No |
| Prevents Withdrawal | Yes | Yes | No (requires completed detox) |
| Blocks Other Opioids | Partially | Partially | Completely |
Sublocade offers distinct advantages for individuals in opioid addiction recovery. Sublocade matters because it provides:
Assessment Component | What We Evaluate | Why It Matters |
Buprenorphine Stability | Minimum 7 days on stable daily dose (8-24mg) | Ensures therapeutic baseline before conversion |
Dose Optimization | Current buprenorphine dose adequacy | Confirms dosing appropriate for Sublocade transition |
Treatment Engagement | Participation in therapy, appointment attendance | Indicates readiness for monthly injection format |
Diversion Risk | History of medication misuse or diversion | Sublocade eliminates take-home diversion concerns |
Injection Preference | Comfort with monthly injection versus daily medication | Confirms Sublocade aligns with preferences |
Sublocade requires prior stability on daily buprenorphine. Our medical team evaluates readiness for transition.
| Assessment Component | What We Evaluate | Why It Matters |
| Buprenorphine Stability | Minimum 7 days on stable daily dose (8-24mg) | Ensures therapeutic baseline before conversion |
| Dose Optimization | Current buprenorphine dose adequacy | Confirms dosing appropriate for Sublocade transition |
| Treatment Engagement | Participation in therapy, appointment attendance | Indicates readiness for monthly injection format |
| Diversion Risk | History of medication misuse or diversion | Sublocade eliminates take-home diversion concerns |
| Injection Preference | Comfort with monthly injection versus daily medication | Confirms Sublocade aligns with preferences |
Sublocade administration follows precise medical protocols:
Throughout Sublocade treatment, we provide continuous medical support:
Sublocade administration follows precise medical protocols:
Throughout Sublocade treatment, we provide continuous medical support:
Condition | Sublocade Approach |
Heroin Addiction Treatment | Transition from daily buprenorphine once stable; consistent monthly levels prevent breakthrough cravings common with daily dosing variability |
Fentanyl Addiction Treatment | May require higher maintenance doses (300mg) due to fentanyl potency; extended-release format provides reliable coverage for potent synthetic opioids |
Prescription Opioid Addiction | Effective for those transitioning from prescription painkiller dependence; eliminates daily medication that may feel similar to previous pills |
Chronic Relapse Prevention | Monthly injection removes daily adherence challenges that contribute to relapse; medication continues working regardless of motivation fluctuations |
Treatment Transition Support | Simplifies progression through Residential Treatment, IOP, and Addiction Aftercare Services with consistent monthly dosing |
| Condition | Sublocade Approach |
| Heroin Addiction Treatment | Transition from daily buprenorphine once stable; consistent monthly levels prevent breakthrough cravings common with daily dosing variability |
| Fentanyl Addiction Treatment | May require higher maintenance doses (300mg) due to fentanyl potency; extended-release format provides reliable coverage for potent synthetic opioids |
| Prescription Opioid Addiction | Effective for those transitioning from prescription painkiller dependence; eliminates daily medication that may feel similar to previous pills |
| Chronic Relapse Prevention | Monthly injection removes daily adherence challenges that contribute to relapse; medication continues working regardless of motivation fluctuations |
| Treatment Transition Support | Simplifies progression through Residential Treatment, IOP, and Addiction Aftercare Services with consistent monthly dosing |
Our Sublocade program maintains the highest standards of care:
Sublocade works optimally when combined with comprehensive addiction services:
We ensure seamless Sublocade access across treatment phases:
Our Sublocade program maintains the highest standards of care:
Sublocade works optimally when combined with comprehensive addiction services:
We ensure seamless Sublocade access across treatment phases:
Residential Treatment provides optimal conditions for Sublocade initiation or continuation:
Intensive Outpatient Program (IOP) and Virtual IOP continue Sublocade seamlessly:
Addiction Aftercare Services maintain long-term Sublocade support:
Individuals arriving from other treatment settings receive coordinated Sublocade care:
We continuously update our protocols as new research emerges, ensuring you benefit from the latest advances in addiction medicine.
Yes, Sublocade is approved for individuals who have initiated treatment with a transmucosal buprenorphine product (like Suboxone) and have been on a stable dose for at least 7 days. This ensures your body tolerates buprenorphine well and allows dose optimization before transitioning to monthly injections.
Sublocade is a subcutaneous injection in the abdominal area. You may feel brief discomfort during injection and mild soreness afterward. A small lump or bump may form at the injection site – this is normal and is where the medication slowly releases over the month. Most patients tolerate injections well with minimal discomfort.
Both contain buprenorphine, but delivery differs significantly. Suboxone is a daily sublingual film or tablet you take yourself. Sublocade is a monthly injection administered by a healthcare provider. Sublocade provides steadier medication levels and eliminates daily dosing, while Suboxone offers more flexible dose adjustments and can be initiated during active withdrawal.
Yes, transitioning back to daily buprenorphine is possible if Sublocade is not the right fit. Our medical team helps manage any transitions between formulations based on your needs and preferences. The goal is to find the medication approach that best supports your recovery.
Sublocade continues releasing medication for several weeks, providing some buffer if you cannot make your exact appointment date. However, maintaining the monthly schedule is important for optimal effectiveness. If you must reschedule, contact us as soon as possible to arrange an alternative appointment time.
Sublocade transforms buprenorphine treatment from a daily requirement into a monthly appointment. This shift removes the constant reminder of medication dependence, eliminates adherence challenges, and provides consistent relief from cravings throughout each month. For those already benefiting from buprenorphine therapy, Sublocade offers a meaningful upgrade that simplifies recovery.
If you are currently stable on daily buprenorphine and ready to transition to monthly injections, or if you are new to MAT and interested in working toward Sublocade, our medical team is ready to evaluate your situation and develop an appropriate plan.
Contact Addiction Recovery Center at (866) 502-4344 or visit our Contact Us page for a free, confidential assessment to begin your journey toward recovery and renewed hope.